Invega trinza and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Invega trinza (paliperidone palmitate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Invega Sustenna, and have Schizophrenia.

The phase IV clinical study analyzes which people have Dizziness when taking Invega trinza. It is created by eHealthMe based on reports of 4,027 people who have side effects when taking Invega trinza from the FDA, and is updated regularly.

What is Invega trinza?

Invega trinza has active ingredients of paliperidone palmitate. eHealthMe is studying from 4,035 Invega trinza users. Check the latest studies of Invega trinza.

What is Dizziness?

Dizziness is found to be associated with 3,566 drugs and 5,710 conditions by eHealthMe. Check the latest studies of Dizziness.

On Jul, 09, 2026

4,027 people reported to have side effects when taking Invega trinza.
Among them, 24 people (0.6%) have Dizziness.

Among these 24 people:

How long have people been on Invega trinza when they have Dizziness? *

What is the gender of people who have Dizziness when taking Invega trinza? *

female: 47.83 %
male: 52.17 %

What is the age of people who have Dizziness when taking Invega trinza? *

What are other drugs people take besides Invega trinza? *

What are other side effects people have besides Dizziness? *

Agitation (state of anxiety or nervous excitement): 4 people, 16.67%
Nausea (feeling of having an urge to vomit): 4 people, 16.67%
Hospitalisation: 3 people, 12.50%
Headache (pain in head): 3 people, 12.50%
Fainting (loss of consciousness and postural tone): 3 people, 12.50%
Pain In Extremity: 3 people, 12.50%
Feeling Abnormal: 3 people, 12.50%
Dyspnea (difficult or laboured breathing): 3 people, 12.50%
Nausea And Vomiting: 3 people, 12.50%
Thinking Abnormal: 3 people, 12.50%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 11 people, 45.83%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 12.50%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 4.17%
Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 1 person, 4.17%
Insomnia (sleeplessness): 1 person, 4.17%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 4.17%
Depression: 1 person, 4.17%
Dementia (madness): 1 person, 4.17%
Agitation (state of anxiety or nervous excitement): 1 person, 4.17%
Affective Disorder (mental disorder): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Invega trinza and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invega trinza:

Invega trinza (4,035 reports)

Dizziness treatments and more:

Dizziness (613,960 reports)

Browse all side effects of Invega trinza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,566 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,710 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Invega trinza) and Invega trinza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.